Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

publication venue for

Impact of Vaginal Estradiol on the Genitourinary Syndrome of Menopause, Vaginal Microbiome and Mucosal Immune Mediators in Women With HIV.. 82:e710-e719. 2026
In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort.. 82:575-582. 2026
A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391). 2026
2026 Clinical Practice Guideline Update by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Choice of Chest Tube Size. 2026
2026 Clinical Practice Guideline Update by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of tPa and DNase or tPa Alone for Fibrinolysis. 2026
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024.. 82:e595-e603. 2026
Implementation of Diagnostic Stewardship to Improve Urinary Tract Infection Antibiotic Use Across 3 Medical Centers.. 82:494-500. 2026
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.. 82:e561-e570. 2026
The Bounce-Back Effect: What Happens After Cessation of Low-Dose Semaglutide in People with HIV.. 82:e544-e548. 2026
2026 Clinical Practice Guideline Update by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of Chest Ultrasound in Children with Parapneumonic Effusion. 2026
2026 Clinical Practice Guideline Update by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of Pleural Fluid Drainage versus Observation. 2026
2026 Clinical Practice Guideline Update by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of Pleural fluid drainage compared to Surgical Debridement. 2026
Clinical Practice Guideline by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society: 2026 Guideline Update on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age. 2026
Risk Assessment in a Global CVD Prevention Cohort of People With HIV by PCE, PREVENT, and SCORE2.. 82:e248-e257. 2026
Overview of 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults. 2026
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial.. 81:e560-e567. 2026
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV.. 81:e548-e557. 2026
Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study.. 81:S249-S255. 2026
Incidence of AIDS-Defining Conditions Among Adults With Perinatally Acquired HIV After Transition to Adult HIV Care in the United States and Canada, 2000-2022.. 81:962-969. 2025
Translating HDV Screening Cost-Effectiveness into Practice: the Case for Reflex Testing in the United States.. 81:e474-e475. 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults. 2025
Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures. 2025
Changes in the Prevalence of Non-AIDS Conditions Among Hospitalized Persons With HIV in the United States and Canada, 2008-2018.. 81:806-814. 2025
Influenza Vaccine Effectiveness Against Medically Attended Outpatients Illness, United States, 2023-2024 Season.. 81:e184-e191. 2025
Behavioral Boosts, Getting More Bang for Your Buck: Financial Incentives for Outpatient Antibiotic Stewardship.. 81:610-612. 2025
HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based Cohort Study.. 81:427-438. 2025
Impact of a Collaboration-Focused Intervention to Prevent Healthcare-Associated Infections Before and During the COVID-19 Pandemic.. 81:358-368. 2025
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.. 81:190-197. 2025
Target Trial Emulation of SARS-CoV-2 Infection Versus No Infection and Risk of Post-COVID-19 Conditions in the Omicron Variant Versus Prior Eras.. 81:10-19. 2025
Application of Pragmatic Criteria to Assessments of Frailty and Physical Function Among People With HIV.. 80:1229-1234. 2025
Global Trends in CD4 Count Measurement and Distribution at First Antiretroviral Treatment Initiation.. 80:1332-1336. 2025
Long COVID Incidence Proportion in Adults and Children Between 2020 and 2024: An Electronic Health Record-Based Study From the RECOVER Initiative.. 80:1247-1261. 2025
Switch to Integrase Strand Transfer Inhibitors During the Menopausal Transition Is Associated With Accelerated Body Composition Change in Women With HIV.. 80:1125-1132. 2025
The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV.. 80:871-880. 2025
Executive Summary: State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.. 80:491-493. 2025
Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons With HIV Differs by Sex.. 80:575-584. 2025
State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.. 80:e31-e42. 2025
Audit and Feedback Interventions for Antibiotic Prescribing in Primary Care: A Systematic Review and Meta-analysis.. 80:253-262. 2025
Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study.. 80:389-396. 2025
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function.. 80:425-433. 2025
Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia Among Adults Hospitalized With Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022.. 79:838-847. 2024
Performance of Urinalysis Parameters in Predicting Urinary Tract Infection: Does One Size Fit All?. 79:600-603. 2024
Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data.. 79:312-320. 2024
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.. 79:354-363. 2024
HIV, HIV-Specific Factors, and Myocardial Disease in Women.. 79:451-461. 2024
The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons.. 79:339-347. 2024
Cefoxitin for Intra-amniotic Infections and Endometritis: A Retrospective Comparison to Traditional Antimicrobial Therapy Regimens Within a Healthcare System.. 79:247-254. 2024
Unlinking Time Zero From Test-Negative Controls Exaggerates Risk From COVID-19.. 79:273-274. 2024
Excellence in Antibiotic Stewardship: A Mixed-Methods Study Comparing High-, Medium-, and Low-Performing Hospitals.. 78:1412-1424. 2024
Polypharmacy Is Associated With Slow Gait Speed and Recurrent Falls in Older People With HIV.. 78:1608-1616. 2024
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.. 78:1056-1064. 2024
Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease.. 78:395-401. 2024
The Xpert® MTB/RIF cycle threshold value predicts M. tuberculosis transmission to close contacts in a Brazilian prospective multicenter cohort. 2024
Infectious Inequity: How the Gut Microbiome and Social Determinants of Health May Contribute to Clostridioides difficile Infection Among Racial and Ethnic Minorities.. 77:S455-S462. 2023
A Multicenter Retrospective Cohort Study to Characterize Patients Hospitalized With Multisystem Inflammatory Syndrome in Adults and Coronavirus Disease 2019 in the United States, 2020-2021.. 77:1395-1405. 2023
Vitamin C Urinary Loss and Deficiency in Human Immunodeficiency Virus (HIV): Cross-sectional Study of Vitamin C Renal Leak in Women With HIV.. 77:1157-1165. 2023
Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.. 77:703-710. 2023
Body Composition Changes Over the Menopausal Transition in Women With and Without Human Immunodeficiency Virus.. 77:265-271. 2023
Health Insurance and Initiation of Direct-Acting Antivirals for Hepatitis C in US Women With Human Immunodeficiency Virus.. 77:258-264. 2023
Your Outpatient has Coronavirus Disease 2019: What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate?. 77:32-37. 2023
Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View.. 76:2116-2125. 2023
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.. 76:1727-1734. 2023
Plasma Aβ42/Aβ40 Ratios in Older People With Human Immunodeficiency Virus.. 76:1776-1783. 2023
Cytomegalovirus IgG Titer and Coronary Artery Disease in People with HIV.. 76:e613-e621. 2023
Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study.. 76:461-468. 2023
Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.. 76:e1-e9. 2023
Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus.. 76:e661-e670. 2023
The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce.. 76:e34-e41. 2023
Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome.. 76:e930-e937. 2023
Human Immunodeficiency Virus and Cardiac End-Organ Damage in Women: Findings From an Echocardiographic Study Across the United States.. 76:210-219. 2023
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.. 76:323-334. 2023
Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.. 77:703-710. 2023
Rapid Environmental Contamination with Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients. 2023
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.. 75:1324-1333. 2022
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.. 75:1154-1163. 2022
Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America.. 75:297-304. 2022
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.. 75:e361-e367. 2022
Human Immunodeficiency Virus (HIV) and Menopause Are Independently Associated With Lower Bone Mineral Density: Results From the Women's Interagency HIV Study.. 75:65-72. 2022
Defining Antibiotic Inertia: Application of a Focused Clinical Scenario Survey to Illuminate A New Target for Antimicrobial Stewardship During Transitions of Care.. 74:2050-2052. 2022
Factors Associated With Readmission in the United States Following Hospitalization With Coronavirus Disease 2019.. 74:1713-1721. 2022
Evaluation of the Infectious Diseases Society of America's Core Antimicrobial Stewardship Curriculum for Infectious Diseases Fellows.. 74:965-972. 2022
Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living With Human Immunodeficiency Virus.. 74:1101-1106. 2022
Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature.. 74:479-489. 2022
Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.. 74:416-426. 2022
A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.. 74:973-982. 2022
Enterococcus Intestinal Domination is Associated with Increased Mortality in the Acute Leukemia Chemotherapy Population.. 78:414-22. 2021
Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System.. 73:e4124-e4130. 2021
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019.. 73:e4197-e4205. 2021
Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-19) Mortality Risk Across Age Groups: 66 646 Inpatients Across 613 U.S. Hospitals.. 73:e4113-e4123. 2021
Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis.. 73:e3459-e3467. 2021
Risk Factors for Testing Positive for Severe Acute Respiratory Syndrome Coronavirus 2 in a National United States Healthcare System.. 73:e3085-e3094. 2021
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials.. 73:1440-1451. 2021
Breaking the Ambulatory Antibiotic Prescribing Cycle with All-Antibiotic Stewardship, Patient Stewardship, and Visit Stewardship.. 73:e1680-e1683. 2021
CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.. 73:e2334-e2337. 2021
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health Administration.. 73:1231-1238. 2021
Investing in the Future: A Role for Professional Societies to Prepare the Next Generation of Healthcare Leaders Through Curriculum Development and Dissemination.. 73:911-918. 2021
Baseline Neurocognitive Impairment (NCI) Is Associated With Incident Frailty but Baseline Frailty Does Not Predict Incident NCI in Older Persons With Human Immunodeficiency Virus (HIV).. 73:680-688. 2021
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.. 73:344-350. 2021
Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies.. 72:e887-e889. 2021
Reply to Rhoads, et al.. 72:-. 2021
Striving to Reach the Optimal Measure for Catheter-Associated Urinary Tract Infection (CAUTI): Moving to Catheter Harm.. 72:-. 2021
Antiretroviral Therapy Initiation Is Associated With Decreased Visceral and Subcutaneous Adipose Tissue Density in People Living With Human Immunodeficiency Virus.. 72:979-986. 2021
Food Insecurity and T-cell Dysregulation in Women Living With Human Immunodeficiency Virus on Antiretroviral Therapy.. 72:e112-e119. 2021
Optimizing Use of Antibiotics and Antivirals in Ambulatory Patients With Influenza.. 72:574-575. 2021
Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities.. 72:S8-S16. 2021
Appropriateness of Antibiotic Prescribing for Acute Sinusitis in Primary Care: A Cross-sectional Study.. 72:311-314. 2021
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.. 72:301-308. 2021
Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis.. 73:e1273-e1281. 2021
Application of Combined Genomic and Transfer Analyses to Identify Factors Mediating Regional Spread of Antibiotic-resistant Bacterial Lineages.. 71:e642-e649. 2020
Reply to Evans et al.. 71:2770-2771. 2020
Gut Microbiota Features on Nursing Home Admission Are Associated With Subsequent Acquisition of Antibiotic-resistant Organism Colonization.. 71:3244-3247. 2020
Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus.. 71:2345-2353. 2020
Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living With Human Immunodeficiency Virus in the United States (2005-2016).. 71:2405-2413. 2020
Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.. 71:e471-e477. 2020
The Effectiveness of Contact Precautions on Methicillin-Resistant Staphylococcus aureus in Long-term Care Across the United States.. 71:1676-1683. 2020
Food Insecurity Is Associated With Lower Levels of Antiretroviral Drug Concentrations in Hair Among a Cohort of Women Living With Human Immunodeficiency Virus in the United States.. 71:1517-1523. 2020
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.. 71:1379-1389. 2020
Sex- and Poverty-Specific Patterns in Cardiovascular Disease Mortality Associated With Human Immunodeficiency Virus, New York City, 2007-2017.. 71:491-498. 2020
Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.. 71:593-600. 2020
Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy.. 70:1267-1274. 2020
Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection.. 71:1905-1911. 2020
Increased Mortality After Tuberculosis Treatment Completion in Persons Living With Human Immunodeficiency Virus in Latin America.. 71:215-217. 2020
Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases Society of America Strategic Plan.. 69:e1-e7. 2019
Multidrug-resistant Organisms in Hospitals: What Is on Patient Hands and in Their Rooms?. 69:1837-1844. 2019
The Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency Virus.. 69:1613-1620. 2019
Frailty Is an Independent Risk Factor for Mortality, Cardiovascular Disease, Bone Disease, and Diabetes Among Aging Adults With Human Immunodeficiency Virus.. 69:1370-1376. 2019
Model-based Assessment of the Effect of Contact Precautions Applied to Surveillance-detected Carriers of Carbapenemase-producing Enterobacteriaceae in Long-term Acute Care Hospitals.. 69:S206-S213. 2019
Understanding Workflow and Personal Protective Equipment Challenges Across Different Healthcare Personnel Roles.. 69:S185-S191. 2019
Differences in the Impact of Pneumococcal Serotype Replacement in Individuals With and Without Underlying Medical Conditions.. 69:100-106. 2019
Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge.. 68:1887-1893. 2019
Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus.. 68:131-138. 2019
Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study.. 69:1027-1035. 2019
Antimicrobial Stewardship Training for Infectious Diseases Fellows: Program Directors Identify a Curriculum Need.. 67:1285-1287. 2018
Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Colonization.. 67:861-868. 2018
Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population.. 67:837-844. 2018
The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed Among Older Men Living With Human Immunodeficiency Virus.. 67:778-784. 2018
Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.. 66:893-903. 2018
The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.. 65:2042-2049. 2017
Implementing Antimicrobial Stewardship in Long-term Care Settings: An Integrative Review Using a Human Factors Approach.. 65:1943-1951. 2017
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.. 65:1316-1326. 2017
Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.. 65:100-106. 2017
Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection.. 65:83-91. 2017
Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia.. 64:1486-1493. 2017
Infection Prevention Practices in Japan, Thailand, and the United States: Results From National Surveys.. 64:S105-S111. 2017
Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection.. 64:1422-1429. 2017
HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers.. 64:468-475. 2017
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.. 63:1661-1667. 2016
Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.. 63:999-1006. 2016
The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.. 63:694-702. 2016
Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.. 63:1-9. 2016
Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.. 61:1566-72. 2015
Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates.. 61:1235-43. 2015
HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis.. 61:640-50. 2015
Enhancing Resident Safety by Preventing Healthcare-Associated Infection: A National Initiative to Reduce Catheter-Associated Urinary Tract Infections in Nursing Homes.. 61:86-94. 2015
Reply to Haddow et al.. 60:1442-3. 2015
RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration.. 61Suppl 3:S155-9. 2015
Editorial commentary: Preventing aspiration pneumonia in high-risk nursing home residents: role of chlorhexidine-based oral care questioned again.. 60:858-9. 2014
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.. 60:473-80. 2014
The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.. 60:646-52. 2014
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.. 59:e96-138. 2014
Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations.. 59:920-2. 2014
Reply to Sachdev et al.. 58:-. 2014
Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.. 58:997-1002. 2013
A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.. 58:883-90. 2013
Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada.. 58:704-12. 2013
Infection prevention in the cancer center.. 57:579-85. 2013
Urinary tract infections: current and emerging management strategies.. 57:719-24. 2013
Traditional chinese medicine: an alternative treatment option for refractory recurrent urinary tract infections.. 56:-. 2013
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.. 54:922-8. 2012
Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease.. 54:408-13. 2011
Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.. 52:1267-75. 2011
Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit.. 52:1108-1115. 2011
Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices.. 52:654-61. 2011
Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China.. 52:692-3. 2011
Immunosenescence and vaccination in nursing home residents.. 48:443-8. 2009
Editorial commentary: antibiotics for treatment of acute respiratory tract infections: decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance.. 47:744-6. 2008
Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.. 47:56-62. 2008
Secondary syphilis with ocular manifestations in older adults.. 46:e142-5. 2008
Epidemiology of Staphylococcus aureus colonization in nursing home residents.. 46:1368-73. 2008
Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.. 46:305-12. 2008
Preventing hospital-acquired urinary tract infection in the United States: a national study.. 46:243-50. 2008
Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.. 46:30-6. 2008
Improving care for acute respiratory infections: better systems, not better microbiology.. 45:1189-91. 2007
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.. 45:992-8. 2007
Suburban leptospirosis: atypical lymphocytosis and gamma-delta T cell response.. 43:1304-7. 2006
Influenza deaths in spite of immunization and prophylaxis.. 40:492-3. 2005
Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial.. 37:1467-74. 2003
Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.. 34:340-5. 2001
Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop.. 33:1573-8. 2001
Photo quiz. Pulmonary tuberculosis.. 27:1137, 1318-9. 1998
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.. 25:1056-9. 1997
Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years.. 24:514-5. 1997
Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia among Adults Hospitalized with Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022 2024
The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons 2024
The Impact of Sociodemographic Factors, Comorbidities, and Physiologic Responses on 30-Day Mortality in Coronavirus Disease 2019 (COVID-19) Patients in Metropolitan Detroit 2021
The Impact of Sociodemographic Factors, Comorbidities, and Physiologic Responses on 30-Day Mortality in Coronavirus Disease 2019 (COVID-19) Patients in Metropolitan Detroit 2021
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19 2020
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19 2020
Bedbugs and Vector-Borne Diseases 2014
Bedbugs and vector-borne diseases 2014
Bedbugs and vector-borne diseases 2014
Bedbugs and vector-borne diseases 2014
Psychotropic Medications and HIV 2006

Clin-STAR Database

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Journal

Overview

publication venue for

Identity

International Standard Serial Number (ISSN)